COVID-19 infection and 2-year mortality in nursing home residents who survived the first wave of the pandemic.


Journal

BMC geriatrics
ISSN: 1471-2318
Titre abrégé: BMC Geriatr
Pays: England
ID NLM: 100968548

Informations de publication

Date de publication:
01 Aug 2024
Historique:
received: 16 03 2024
accepted: 15 07 2024
medline: 2 8 2024
pubmed: 2 8 2024
entrez: 1 8 2024
Statut: epublish

Résumé

During the first COVID-19 pandemic wave (1st CoPW), nursing homes (NHs) experienced a high rate of COVID-19 infection and death. Residents who survived the COVID-19 infection may have become frailer. This study aimed to determine the predictive value of having a COVID-19 infection during the 1st CoPW for 2-year mortality in NH residents. This was a retrospective study conducted in three NHs. Residents who had survived the 1st CoPW (March to May 2020) were included. The diagnosis of COVID-19 was based on the results of a positive reverse transcriptase-polymerase chain reaction test. The collected data also included age, sex, length of residence in the NH, disability status, legal guardianship status, nutritional status, need for texture-modified food, hospitalization or Emergency Department visits during lockdown and SARS-COV2 vaccination status during the follow-up. Non-adjusted and adjusted Cox models were used to analyse factors associated with 2-year post-1st CoPW mortality. Among the 315 CoPW1 survivors (72% female, mean age 88 years, 48% with severe disability), 35% presented with COVID-19. Having a history of COVID-19 was not associated with 2-year mortality: hazard ratio (HR) [95% confidence interval] = 0.96 [0.81-1.13], p = 0.62. The factors independently associated with 2-year mortality were older age (for each additional year, HR = 1.05 [1.03-1.08], p < 0.01), severe disability vs. moderate or no disability (HR = 1.35 [1.12-1.63], p < 0.01) and severe malnutrition vs. no malnutrition (HR = 1.29 [1.04-1.60], p = 0.02). Considering that vaccination campaign started during the follow-up, mortality was associated with severe malnutrition before and severe disability after the start of the campaign. Vaccination was independently associated with better survival (HR 0.71 [0.55-0.93], p = 0.02). Having survived a COVID-19 infection during the 1st CoPW did not affect subsequent 2-year survival in older adults living in NHs. Severe malnutrition and disability remained strong predictor of mortality in this population, whereas vaccination was associated to better survival.

Sections du résumé

BACKGROUND BACKGROUND
During the first COVID-19 pandemic wave (1st CoPW), nursing homes (NHs) experienced a high rate of COVID-19 infection and death. Residents who survived the COVID-19 infection may have become frailer. This study aimed to determine the predictive value of having a COVID-19 infection during the 1st CoPW for 2-year mortality in NH residents.
METHODS METHODS
This was a retrospective study conducted in three NHs. Residents who had survived the 1st CoPW (March to May 2020) were included. The diagnosis of COVID-19 was based on the results of a positive reverse transcriptase-polymerase chain reaction test. The collected data also included age, sex, length of residence in the NH, disability status, legal guardianship status, nutritional status, need for texture-modified food, hospitalization or Emergency Department visits during lockdown and SARS-COV2 vaccination status during the follow-up. Non-adjusted and adjusted Cox models were used to analyse factors associated with 2-year post-1st CoPW mortality.
RESULTS RESULTS
Among the 315 CoPW1 survivors (72% female, mean age 88 years, 48% with severe disability), 35% presented with COVID-19. Having a history of COVID-19 was not associated with 2-year mortality: hazard ratio (HR) [95% confidence interval] = 0.96 [0.81-1.13], p = 0.62. The factors independently associated with 2-year mortality were older age (for each additional year, HR = 1.05 [1.03-1.08], p < 0.01), severe disability vs. moderate or no disability (HR = 1.35 [1.12-1.63], p < 0.01) and severe malnutrition vs. no malnutrition (HR = 1.29 [1.04-1.60], p = 0.02). Considering that vaccination campaign started during the follow-up, mortality was associated with severe malnutrition before and severe disability after the start of the campaign. Vaccination was independently associated with better survival (HR 0.71 [0.55-0.93], p = 0.02).
CONCLUSIONS CONCLUSIONS
Having survived a COVID-19 infection during the 1st CoPW did not affect subsequent 2-year survival in older adults living in NHs. Severe malnutrition and disability remained strong predictor of mortality in this population, whereas vaccination was associated to better survival.

Identifiants

pubmed: 39090548
doi: 10.1186/s12877-024-05220-w
pii: 10.1186/s12877-024-05220-w
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

647

Informations de copyright

© 2024. The Author(s).

Références

Team EPHE, Danis K, Fonteneau L, Georges S, Daniau C, Bernard-Stoecklin S, et al. High impact of COVID-19 in long-term care facilities, suggestion for monitoring in the EU/EEA, May 2020. Eurosurveillance. 2020;25(22):2000956.
Graham NSN, Junghans C, Downes R, Sendall C, Lai H, McKirdy A, et al. SARS-CoV-2 infection, clinical features and outcome of COVID-19 in United Kingdom nursing homes. J Infect. 2020;81(3):411–9.
doi: 10.1016/j.jinf.2020.05.073 pubmed: 32504743 pmcid: 7836316
Cangiano B, Fatti LM, Danesi L, Gazzano G, Croci M, Vitale G, et al. Mortality in an Italian nursing home during COVID-19 pandemic: correlation with gender, age, ADL, vitamin D supplementation, and limitations of the diagnostic tests. Aging. 2020;12(24):24522–34.
doi: 10.18632/aging.202307 pubmed: 33353888 pmcid: 7803543
Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020;323(18):1775–6.
pubmed: 32203977
Greco GI, Noale M, Trevisan C, Zatti G, Dalla Pozza M, Lazzarin M, et al. Increase in Frailty in nursing home survivors of Coronavirus Disease 2019: comparison with noninfected residents. J Am Med Dir Assoc. 2021;22(5):943–e9473.
doi: 10.1016/j.jamda.2021.02.019 pubmed: 33757725 pmcid: 7898983
Van Der Krogt IEJ, Sizoo EM, Van Loon AM, Hendriks SA, Smalbrugge M. The recovery after COVID-19 in nursing home residents. Gerontol Geriatric Med. 2022;8:233372142210941.
doi: 10.1177/23337214221094192
Prampart S, Le Gentil S, Bureau ML, Macchi C, Leroux C, Chapelet G, et al. Functional decline, long term symptoms and course of frailty at 3-months follow-up in COVID-19 older survivors, a prospective observational cohort study. BMC Geriatr. 2022;22(1):542.
doi: 10.1186/s12877-022-03197-y pubmed: 35768781 pmcid: 9244035
Taniguchi LU, Avelino-Silva TJ, Dias MB, Jacob-Filho W, Aliberti MJR, COVID-19 and Frailty (CO-FRAIL) Study Group and EPIdemiology of Critical COVID-19 (EPICCoV. Study Group, for COVID Hospital Das Clinicas, University of Sao Paulo Medical School (HCFMUSP) Study Group. Patient-centered outcomes following COVID-19: Frailty and disability transitions in critical care survivors. Crit Care Med. 2022;50(6):955–63.
doi: 10.1097/CCM.0000000000005488 pubmed: 35081061 pmcid: 9112506
Taniguchi LU, Aliberti MJR, Dias MB, Jacob-Filho W, Avelino-Silva TJ. Twelve months and counting: following clinical outcomes in critical COVID-19 survivors. Ann Am Thorac Soc. 2023;20(2):289–95.
doi: 10.1513/AnnalsATS.202207-630OC pubmed: 36179057 pmcid: 9989854
Booij JA, van de Haterd JCHQ, Huttjes SN, van Deijck RHPD, Koopmans RTCM. Short- and long-term mortality and mortality risk factors among nursing home patients after COVID-19 infection. J Am Med Dir Assoc. 2022;23(8):1274–8.
doi: 10.1016/j.jamda.2022.06.005 pubmed: 35809633 pmcid: 9212799
Courtois-Amiot P, Allart H, de Cathelineau C, Legué C, Eischen P, Chetaille F et al. Covid-19 as an Independent Risk Factor for Weight Loss in Older Adults living in Nursing Homes. Gerontology. 2023.
Cederholm T, Jensen GL, Correia MITD, Gonzalez MC, Fukushima R, Higashiguchi T, et al. GLIM criteria for the diagnosis of malnutrition - A consensus report from the global clinical nutrition community. Clin Nutr. 2019;38(1):1–9.
doi: 10.1016/j.clnu.2018.08.002 pubmed: 30181091
Aguilova L, Sauzéon H, Balland É, Consel C, N’Kaoua B. Grille AGGIR Et aide à La spécification des besoins des personnes âgées en perte d’autonomie. Rev Neurol. 2014;170(3):216–21.
doi: 10.1016/j.neurol.2014.01.039 pubmed: 24630760
Sánchez-Rodríguez D, De Meester D, Minon L, Claessens M, Gümüs N, Lieten S, et al. Association between Malnutrition assessed by the Global Leadership Initiative on Malnutrition Criteria and Mortality in Older people: a scoping review. IJERPH. 2023;20(7):5320.
doi: 10.3390/ijerph20075320 pubmed: 37047936 pmcid: 10094645
Rothera IC, Jones R, Harwood R, Avery AJ, Waite J. Survival in a cohort of social services placements in nursing and residential homes: factors associated with life expectancy and mortality. Public Health. 2002;116(3):160–5.
pubmed: 12082598
Incalzi RA, Capparella O, Gemma A, Landi F, Bruno E, Di Meo F, et al. The interaction between age and comorbidity contributes to predicting the mortality of geriatric patients in the acute-care hospital. J Intern Med. 1997;242(4):291–8.
doi: 10.1046/j.1365-2796.1997.00132.x pubmed: 9366807
Dessie ZG, Zewotir T. Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients. BMC Infect Dis. 2021;21(1):855.
doi: 10.1186/s12879-021-06536-3 pubmed: 34418980 pmcid: 8380115
Zerah L, Baudouin É, Pépin M, Mary M, Krypciak S, Bianco C et al., Clinical characteristics and outcomes of 821 older patients with SARS-Cov-2 infection admitted to acute care geriatric wards. J Gerontol A Biol Sci Med Sci. 2021;76(3):e4–e12.
Whitson HE, Duan-Porter W, Schmader KE, Morey MC, Cohen HJ, Colón-Emeric CS. Physical resilience in older adults: systematic review and development of an emerging construct. J Gerontol Biol Sci Med Sci. 2016;71(4):489–95.
doi: 10.1093/gerona/glv202
Pearson-Stuttard J, Caul S, McDonald S, Whamond E, Newton JN. Excess mortality in England post COVID-19 pandemic: implications for secondary prevention. Lancet Reg Health Eur. 2024;36:100802.
doi: 10.1016/j.lanepe.2023.100802 pubmed: 38188277
Chen R, Charpignon ML, Raquib RV, Wang J, Meza E, Aschmann HE, et al. Excess mortality with Alzheimer Disease and related dementias as an underlying or contributing cause during the COVID-19 pandemic in the US. JAMA Neurol. 2023;80(9):919–28.
doi: 10.1001/jamaneurol.2023.2226 pubmed: 37459088 pmcid: 10352932
Fulop T, Pawelec G, Castle S, Loeb M. Immunosenescence and vaccination in nursing home residents. Clin Infect Dis. 2009;48(4):443–8.
doi: 10.1086/596475 pubmed: 19140756
Dosil-Díaz C, Pinazo-Hernandis S, Pereiro AX, Facal D. The impact of the COVID-19 pandemic on nursing home professionals: results of the RESICOVID project. Psicol Reflex Crit. 2024;37(1):11.
doi: 10.1186/s41155-023-00284-w pubmed: 38502288 pmcid: 10951143

Auteurs

Manuel Sanchez (M)

Geriatric Department, AP-HP, Bichat and Beaujon University Hospitals, 46 rue Henri Huchard, Paris Cedex , 75877, France. manuel.sanchez@aphp.fr.
Paris Cité University, Paris, France. manuel.sanchez@aphp.fr.
Gérond'if, Paris, France. manuel.sanchez@aphp.fr.

Pauline Courtois-Amiot (P)

Geriatric Department, AP-HP, Bichat and Beaujon University Hospitals, 46 rue Henri Huchard, Paris Cedex , 75877, France.

Vincent Herrault (V)

Geriatric Department, AP-HP, Bichat and Beaujon University Hospitals, 46 rue Henri Huchard, Paris Cedex , 75877, France.

Hélène Allart (H)

Geriatric Department, AP-HP, Bichat and Beaujon University Hospitals, 46 rue Henri Huchard, Paris Cedex , 75877, France.

Philippe Eischen (P)

Fondation Roguet Nursing Home, Clichy, France.

Fabienne Chetaille (F)

Les Artistes de Batignolles Nursing Home, Paris, France.

Denise Lepineux (D)

Fondation COS Jacques Barrot Nursing Home, Paris, France.

Castille de Cathelineau (C)

Geriatric Department, AP-HP, Bichat and Beaujon University Hospitals, 46 rue Henri Huchard, Paris Cedex , 75877, France.

Agathe Raynaud-Simon (A)

Geriatric Department, AP-HP, Bichat and Beaujon University Hospitals, 46 rue Henri Huchard, Paris Cedex , 75877, France.
Paris Cité University, Paris, France.
Gérond'if, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH